These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10348700)

  • 1. Lipoprotein(a) levels and isoforms and fibrinolytic activity in postmenopause--influence of hormone replacement therapy.
    Estellés A; Cano A; Falcó C; España F; Gilabert J; Grancha S; Aznar J
    Thromb Haemost; 1999 Jan; 81(1):104-10. PubMed ID: 10348700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy.
    Falcó C; Tormo G; Estellés A; España F; Tormo E; Gilabert J; Velasco JA; Aznar J
    Haematologica; 2001 Jan; 86(1):92-8. PubMed ID: 11146577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of lipoprotein (a) levels and isoforms on fibrinolytic activity--study in families with high lipoprotein (a) levels.
    Falcó C; Estellés A; Dalmau J; España F; Aznar J
    Thromb Haemost; 1998 Apr; 79(4):818-23. PubMed ID: 9580386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipids, lipoprotein Lp(a), apolipoproteins, and hemostatic risk factors distributions in postmenopausal women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Reiner Z; Zrinski R
    Acta Med Croatica; 1999; 53(2):61-6. PubMed ID: 10705622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma PAI-1 levels in obese children--effect of weight loss and influence of PAI-1 promoter 4G/5G genotype.
    Estellés A; Dalmau J; Falcó C; Berbel O; Castelló R; España F; Aznar J
    Thromb Haemost; 2001 Aug; 86(2):647-52. PubMed ID: 11522017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma Lp (a) levels and correlation of Lp (a) with fibrinolysis activation in chronic renal failure].
    Zhu J; Xiong X; Zhao S; Wang Z; Lou L; Hang Q
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):366-8. PubMed ID: 12080650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels.
    Sieminska L; Wojciechowska C; Niedziolka D; Marek B; Kos-Kudla B; Kajdaniuk D; Nowak M
    Metabolism; 2005 Dec; 54(12):1610-4. PubMed ID: 16311093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of postmenopausal hormone replacement therapy with transdermal estradiol on sensitivity to activated protein C.
    De Mitrio V; Marino R; Cicinelli E; Galantino P; Di Bari L; Giannoccaro F; De Pergola G; Lapecorella M; Schonauer S; Schiraldi O
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):175-82. PubMed ID: 10759011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between plasma viscosity and cholesterol in postmenopausal women on hormone replacement therapy.
    Konukoglu D; Serin O; Ercan M
    Clin Hemorheol Microcirc; 2000; 22(3):223-8. PubMed ID: 10976716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the effect of obesity on selected haemostatic and fibrinolytic parameters in peri- and postmenopausal women].
    Połać I; Stetkiewicz T; Stachowiak G; Jedrzejczyk S; Pertyński T; Pakalski A; Kowalska E
    Pol Merkur Lekarski; 2002 Sep; 13(75):182-4. PubMed ID: 12474565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the cessation of long-term hormone replacement therapy on plasma plasminogen activator inhibitor-1 and fibrinogen.
    Kalela A; Jokela H; Lehtimäki T; Uppa H; Kunnas T; Teisala K; Punnonen R; Nikkari ST
    Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):217-20. PubMed ID: 16337074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship of lipoprotein(a) to fibrinolytic activities in healthy subjects].
    Xiong X; Zhao S; Wang Z; Lo L; Huang Q
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):555-7. PubMed ID: 10806767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A strong inverse relationship between PAI-1 and Lp(a) in hypertensive Type 2 diabetic patients.
    Testa R; Bonfigli AR; Sirolla C; Pieri C; Marra M; Antonicelli R; Manfrini S; Compagnucci P; Testa I
    Diabetes Nutr Metab; 1999 Dec; 12(6):400-6. PubMed ID: 10782561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy.
    Sartori MT; Rigotti P; Marchini F; Spiezia L; Baldan N; Furian L; Varvarikis C; Girolami A
    Transplantation; 2003 Apr; 75(7):994-8. PubMed ID: 12698086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.